Page 4 - Markl Wolf News Today

BOSTON – A former Massachusetts attorney and his wife pleaded guilty today in federal court in Boston in connection with various mortgage fraud schemes.

A federal appeals court has affirmed a federal judge’s nonmonetary sanction against Lieff Cabraser Heimann & Bernstein, imposed for its incomplete description of a fee study.

The First Circuit on Wednesday left intact a Massachusetts federal judge's sanctions against Lieff Cabraser Heimann & Bernstein LLP in a fees spat, finding that the lower court didn't abuse its discretion in punishing the firm for misrepresenting a study regarding fee awards in similar cases.

Taiwanese pharmaceutical company PharmaEssentia avoided sanctions and a default judgment on Friday when a Massachusetts federal judge ruled that a previous order for the firm to pay attorneys fees for Austrian pharmaceutical company AOP Orphan during their fight over a €142 million arbitral award had already addressed PharmaEssentia's withholding of discovery.

A First Circuit panel told Lieff Cabraser Heimann & Bernstein LLP on Tuesday that a Massachusetts federal judge may simply double down if the appeals court rules he unfairly dinged the firm for defending a fee award that was later slashed amid overbilling allegations.

Taiwanese pharmaceutical company PharmaEssentia can't escape sanctions in Massachusetts federal court for being tight-lipped during discovery in a feud with Austrian pharmaceutical company AOP Orphan over a €142 million arbitral award, a judge ruled Monday.

Yannick A. Minang, 27, was sentenced by U.S. District Court Judge Patti B. Sarris to more than four years in prison. Read more at Boston.com.

A former Aegerion Pharmaceuticals Inc. salesman convicted of fraud acted "over the law" by boasting that his illegal off-label sales of cholesterol drugs had helped people, a Boston federal judge said Thursday as he handed down a 4½-year sentence.

Taiwanese pharmaceutical company PharmaEssentia renewed its bid to toss litigation over a disputed €142 million ($165 million) arbitral award secured by Austrian pharmaceutical company AOP Orphan, saying a Massachusetts federal court lacks jurisdiction over the suit because the company has insufficient ties to the state.

Austrian pharmaceutical company AOP Orphan is seeking sanctions against Taiwanese pharmaceutical company PharmaEssentia, saying the latter has so far ducked the former's efforts to establish jurisdiction in litigation to enforce a more than €142 million arbitral award that arose from a soured licensing deal.